Lisdexamfetamine dimesylate had no apparent effects on embryo-fetal morphological development or survival when administered orally to pregnant rats and rabbits throughout the period of organogenesis at doses of up to 40 and 120 mg/kg/day, respectively. Disclaimer: The information on this page is provided for educational purposes only and is not https://vyvanseonlinekaufen08642.post-blogs.com/59892653/vyvanse-grundlagen-erklärt